Monoclonal Gammopathy of Undetermined Significance (MGUS) Screen
The MGUS screen measures the presence of abnormal monoclonal proteins in the blood, which can indicate the risk of developing multiple myeloma or related conditions.
The MGUS screen detects abnormal proteins in the blood to assess the risk of blood-related cancers.
Key facts at a glance
- Units
- g/L
- Clinical utility
- screening
- Result kind
- qualitative
- FDA-cleared
- Helena SPE, Sebia Hydrasys
MGUS is a condition characterized by the presence of an abnormal protein, known as a monoclonal protein or M-protein, in the blood. This condition is often asymptomatic and is usually detected during routine blood tests.
The screening test for MGUS involves measuring the levels of M-proteins, which are produced by a single clone of plasma cells. Elevated levels of these proteins can be indicative of MGUS, which may progress to more serious conditions like multiple myeloma.
Regular screening for MGUS is important for individuals at higher risk, such as older adults or those with a family history of blood-related cancers. Early detection can help in monitoring and managing the condition to prevent progression.
Frequently asked questions
What does a positive MGUS screen mean?
Is MGUS a type of cancer?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy